Smoking Status Influences Clinical Outcome in Collagenous Colitis.
暂无分享,去创建一个
J. Bohr | C. Tysk | S. Miehlke | R. Mueller | R. Greinwald | R. Mohrbacher | M. Ström | A. Münch | A. Madisch | O. Bonderup | Ralf Mohrbacher
[1] Ashwin N. Ananthakrishnan,et al. Epidemiology and risk factors for IBD , 2015, Nature Reviews Gastroenterology &Hepatology.
[2] A. Öst,et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial , 2014, Gut.
[3] K. Whelan,et al. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. , 2014, Journal of Crohn's & colitis.
[4] A. Zinsmeister,et al. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] M. Vieth,et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. , 2014, Gastroenterology.
[6] D. Aust,et al. Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy , 2013, Inflammatory bowel diseases.
[7] J. Bohr,et al. Stable Incidence of Collagenous Colitis and Lymphocytic Colitis in Örebro, Sweden, 1999–2008: A Continuous Epidemiologic Study , 2013, Inflammatory bowel diseases.
[8] J. Gisbert,et al. Impact of Current Smoking on the Clinical Course of Microscopic Colitis , 2013, Inflammatory bowel diseases.
[9] J. Gisbert,et al. Epidemiological Risk Factors in Microscopic Colitis: A Prospective Case–Control Study , 2013, Inflammatory bowel diseases.
[10] D. Aust,et al. Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. , 2012, Journal of Crohn's & colitis.
[11] E. Stylianou,et al. Epigenetics: Concepts and relevance to IBD pathogenesis , 2012, Inflammatory bowel diseases.
[12] L. Bianchi,et al. Current and past cigarette smoking significantly increase risk for microscopic colitis , 2012, Inflammatory bowel diseases.
[13] L. Munck,et al. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups , 2011, Alimentary pharmacology & therapeutics.
[14] J. Bohr,et al. Is smoking a risk factor for collagenous colitis? , 2011, Scandinavian journal of gastroenterology.
[15] J. Bohr,et al. Health-related quality of life is impaired in active collagenous colitis. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[16] J. Bohr,et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis , 2009, Inflammatory bowel diseases.
[17] J. Macdonald,et al. Interventions for Treating Microscopic Colitis: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group Systematic Review of Randomized Trials , 2009, The American Journal of Gastroenterology.
[18] P. Lakatos,et al. Smoking in inflammatory bowel diseases: good, bad or ugly? , 2007, World journal of gastroenterology.
[19] M. Stolte,et al. Long‐term follow‐up of collagenous colitis after induction of clinical remission with budesonide , 2005, Alimentary pharmacology & therapeutics.
[20] L. Friedman,et al. Collagenous colitis pathophysiologic considerations , 1991, Digestive Diseases and Sciences.
[21] C. M. Edwards,et al. `Microscopic colitis': classification and terminology , 2002, Histopathology.
[22] K. Wang,et al. Collagenous colitis: a clinicopathologic correlation. , 1987, Mayo Clinic proceedings.